Protocol for Researching Sermorelin:
Prior to research, Sermorelin should first be reconstituted with bacteriostatic water by injecting bacteriostatic water in the vial of Sermorelin. A 500MCG dose (1/10th of the bottle) should be used daily. Sermorelin can be researched for up to 8 weeks. Following a cycle, a break of 30 days should be taken before resuming research.
Sermorelin acetate (INNTooltip International Nonproprietary Name; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.
